glp-1 and muscle growth Done Done Fitness Glucagon-like peptide-1 receptor agonists and
Description
Change in GCL was neither associated with the treatment group nor with GCL volume at baseline (Supplementary Table 4)
It is intended as an evidence-based reference for patients, dietitians, pharmacists and prescribers seeking clarity on how to maintain micronutrient adequacy during GLP-1 therapy
These are generally mild to moderate and often improve over time as your body adjusts to the medication
A provider who knows when you plan to wean can help you prepare, discuss what to expect from treatment, and have a plan ready so you can start promptly when the time is right
